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Regulation of glomerular filtration rate in chronic congestive heart
failure patients. The purpose of this study was to identify the factor(s)
that characterize impaired glomerular filtration rate (GFR) in congestive
heart failure (CHF) patients. We studied 34 patients, measuring sys-
temic hemodynamics, vasoactive hormones, and sodium and volume
status. Renal plasma flow (para-aminohippurate) and GFR (inulin) were
assessed by steady-state clearance techniques. Both linear and multiple
regression analyses were performed. Impaired GFR was characterized
by reduction of renal blood flow and renal fraction of cardiac output,
and by an increase of renal vascular resistance. The correlation
between GFR and filtration fraction (r = 0.492, P < 0.003) indicated
that individuals with greatest impairment of GFR had the lowest
filtration fraction and increased overall renal vascular resistance, indi-
cating dependence of GFR on afferent, rather then efferent vasocon-
striction, under conditions of low renal perfusion. Mean vasoactive
hormones and blood volume were increased, but without clear cut
correlation with GFR. The greatest impairment of GFR was observed in
elderly CHF patients, as renal blood flow and function demonstrated an
age-dependent decline, in addition to the adverse effects of CHF. In a
multiple regression model, renal blood flow and filtration fraction
accounted for 69% and 25%, respectively, of the variability of GFR,
with a co-linear influence of age. Thus, we have identified age-related,
abnormal renal hemodynamic patterns in CHF, and the fragile nature of
GFR in the elderly CHF population.
In chronic congestive heart failure, the reduction of cardiac
output and increase of systemic vascular resistance results in a
reduction of blood flow to several regional vascular beds,
especially the kidney [1—3]. The reduction of renal blood flow is
accompanied by a reduction of glomerular filtration rate (GFR)
and compromised renal excretion of sodium and water, which
contribute to the formation of edema. However, the mecha-
nisms by which GFR is regulated have not been adequately
characterized across a wide spectrum of the congestive heart
failure process. Earlier studies of GFR focused on mild to
moderate heart failure, or valvular heart disease, incorporating
only a small number of patients with severe chronic congestive
heart failure and reduced renal function [1, 2, 4—7]. The influ-
ence of neurohormonal and volume parameters on GFR, over
the spectrum of heart failure, has not been clarified. We have
therefore evaluated the simultaneous influence of age, systemic
and renal hemodynamics, vasoactive hormonal pathways, and
intravascular volume on GFR, in patients with chronic conges-
tive heart failure. The purpose of the study was to determine the
magnitude of GFR impairment, and potential causal mecha-
nisms, in this patient population.
Methods
Patient population
We studied 34 patients with chronic congestive heart failure.
There were 28 males and 6 females ranging in age from 29 to 76
years. Clinical symptomatology, by New York Heart Associa-
tion criteria, ranged from functional Class II to IV. The diag-
nosis of chronic congestive heart failure was established by
chest x-ray, and demonstration of a dilated, functionally im-
paired left ventricle by one or more of the following: echocar-
diogram, radionuclide cineangiogram, or left heart catheteriza-
tion. The etiology of chronic congestive heart failure was
idiopathic (N = 12) or secondary to coronary artery disease (N
= 22). Patients were excluded from the study if they had
coexistent hypertension, valvular heart disease, or evidence of
primary renal disease. All patients had been referred for hemo-
dynamic evaluation of the severity of their congestive heart
failure, and were studied with the approval of the Committee on
Human Rights in Research. Patients were admitted to the
Clinical Research Center following informed consent and were
placed on a constant diet of 100 mEq sodium per day for at least
three days prior to the study. Maintenance digoxin therapy was
administered in the evening, to avoid dosing at the time of the
studies. All patients continued to receive diuretics, but these
were held on study days. Daily oral furosemide ranged from 40
to 200 mg. In addition, hydrochlorothiazide, 50 mg daily, was
administered to seven patients. The majority of patients were
previously treated with vasodilators such as hydralazine, praz-
osin, and nitrates, but these were discontinued at least three to
four days prior to the study. Converting enzyme inhibitors were
not used prior to performance of these studies.
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Assesstnent of renal hemodynamics and function
Renal plasma flow and GFR were estimated by the clearance
of p-aminohippurate (PAH, Merck, Sharp & Dohme) and inulin
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(American Critical Care), respectively. After an overnight fast,
each subject received a 400 to 600 ml oral water load, and oral
water was administered during the study to compensate for
urine losses. The priming doses of PAH and inulin (approxi-
mately 60 ml total volume) were administered into a peripheral
vein followed by a sustaining infusion of PAH and inulin at a
rate of 60 mllhr, to achieve a plasma concentration of 2.5 mg/dl
for PAll and 25 mg/dl for inulin [8, 9]. An indwelling bladder
catheter was placed in all patients to insure complete urine
collections, as patients with congestive heart failure typically
have very low urine flow rates. After an equilibration period of
45 minutes, there were three 30 minute clearance periods. The
three clearance values were averaged together. At the end of
the clearance studies, a 1% neomycin solution was used to
purge the bladder, just prior to removal of the bladder catheter.
PAH and inulin were analyzed by the colorimetric techniques
described by Smith [8] Renal blood flow (RBF) was calculated
as renal plasma flow/1-hematocrit. The renal extraction of PAH
was hot measured. Filtration fraction was calculated as the
GFR to RPF ratio. Renal plasma flow, renal blood flow, and
GFR were expressed as ml/min corrected to 1.73 m2 body
surface area. Renal vascular resistance (RVR) was calculated
from the formula: RVR = (MAP — RAP)/RBF (mm Hg x
mm/liter), where MAP is mean arterial pressure, RAP is mean
right atrial pressure and RBF is renal blood flow (1/mm/i .73 m2).
To determine the influence of aging independent of the conges-
tive heart failure process, our data were analyzed in comparison
to previously published data of age-related renal functional
changes in normal subjects [10], where similar study techniques
were utilized.
Assessment of systemic hemodynamics
On the morning following the renal hemodynamic study,
supine invasive hemodynamics were obtained in all patients
following overnight fast, using previously described techniques
[11]. The hemodynamic parameters that were obtained repre-
sent steady state values following one to two hours of stabili-
zation. Right heart catheterization was performed to determine
right atrial pressure, mean pulmonary artery pressure, and
pulmonary capillary wedge pressure. An arterial cannula was
placed in a radial artery for measurement of mean arterial
pressure. Heart rate was recorded from a precordial electrocar-
diographic lead. Cardiac output (CO) was determined by the
thermodilution technique [11]. Systemic vascular resistance
was calculated from the formula: SVR = (MAP — RAP) x
80/CO (dynes sec . cm5). Renal fraction of cardiac output
was calculated as renal blood flow divided by cardiac output
expressed as percent of cardiac output.
Blood and urine biochemical analyses
Blood for determination of renin, norepinephrine, vasopres-
sin and serum electrolytes was drawn in the morning before the
start of the clearance procedure. Plasma renin activity and
vasopressin were determined by radioimmunoassay [12, 13],
and plasma norepinephrine was determined by radioenzymatic
assay [14]. A 24-hour urine collection was completed on the
morning of the renal hemodynamic study and was analyzed for
excretion of sodium and aldosterone. Sodium was analyzed by
flame photometry, and aldosterone was analyzed by radioim-
munoassay [15]. Plasma volume was estimated by the radio-
Table 1. Overall systemic and renal hemodynamics in CHF patients
Mean SD Range
Sex male/female 28/6 —
Age years 57 12 (29—76)
Systemic hemodynamics
Heartratebpm 70±15 (51—114)
Pressures mm Hg:
mean arterial 86 12 (60—120)
right atrial 10 7 (0—28)
mean pulmonary artery 37 11 (14—61)
pulmonary capillary wedge
Cardiac index liter/minIm2
26 8
1.86 .46
(4—45)
(1.16—2.60)
Systemic vascular resistanced sec cm5 1840 729 (788—4912)
Renal hemodynamics
Renal plasma flow
ml/min/1.73 m2 199 100 (82—485)
Renal blood flow
ml/min/1.73 m2 342 188 (139—839)
Renal fraction of cardiac
output % 10 6 (5—20)
Glomerular filtration rate
ml/minll.73 m2 58 31 (17—132)
Filtration fraction % 29 12 (16—51)
Renal vascular resistance
mm Hg mm/liter 287 158 (86—779)
iodinated albumin (131J) technique [16]; total blood volume was
then calculated by correcting for the hematocrit, and standard-
ized for body size, age, and sex, expressed as percent of
predicted normal volume.
Statistical analysis
The association of GFR with the hemodynamic, neurohor-
monal, and volume parameters was examined by linear regres-
sion. Linear regression analysis was also used to assess the
relationship between the renal hemodynamic and functional
measurements, and age. The relationships among age, conges-
tive heart failure, and renal hemodynamics and function, were
examined using a multivariate multiple regression technique, in
which the age-related slopes calculated for the congestive heart
failure patients were compared to those calculated for normal
subjects (f ratio). A forward stepwise regression analysis was
then performed to evaluate the influence of age, hemodynamic,
hormonal, and volume parameters on GFR. Statistical signifi-
cance was accepted at a level of P < 0.05. All significance levels
in excess of 0.0001 were expressed at this level. Averaged
values were expressed at the mean one standard deviation.
Results
Overall cardiac and renal hemodynamic status
Table 1 summarizes the overall systemic and renal hemody-
namic status of heart failure patients, demonstrating a low mean
arterial pressure, and an increase of right atrial pressure,
pulmonary artery pressure, and pulmonary capillary wedge
pressure. Mean cardiac index was 1.89 liter/min/m2, and was
greater than 2.00 in 12 patients, 1.50 to 2.00 in 13 patients and
less than 1.50 liter/minIm2 in 9 patients. Systemic vascular
resistance was increased, on average, with a wide range of
vascular compensation. Renal hemodynamic and functional
parameters identified moderate-to-severe overall impairment.
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GFR was decreased (58 31 mi/min/! .73 m2), but demonstrated
a wide range (17 to 132 mllmin/1 .73 m2). There was a significant
correlation of GFR with cardiac index (r = 0.353, P < 0.05) and
inverse correlation with systemic vascular resistance (r =
—0.390, P < 0.03). Glomerular filtration rate was directly
correlated with renal plasma flow (r = 0.791), renal blood flow(r = 0.805), and renal fraction of cardiac output (r = 0.800), all
P < 0.001. There was an inverse correlation of GFR with renal
vascular resistance (r = 0.721, P < 0.001). Figure 1 demon-
strates the relationship of GFR to overall cardiac index and
renal blood flow. While there was a direct relationship of
cardiac index with GFR, (Fig. IA, P < 0.05), the r value of
0.353 indicated that only 12% (r2 = 0.12)of the variation in GFR
could be explained by differences in cardiac index. However,
the relationship of renal blood flow to glomerular filtration (r
0.805), revealed a stronger relationship (Fig. 1B, P < 0.001).
When GFR was correlated with renal fraction of cardiac output
(Fig. 1C), a similar strong correlation was observed (r = 0.800,
P < 0.001).
Relationship of vasoactive hormones, blood volume and
sodium characteristics to GFR
Mean values, and ranges (shown in parentheses) for hor-
monal and volume parameters were as follows: plasma renin
activity (ng/mI/hr) was 13 19 (0.31 to 81); urinary aldosterone
excretion (mg/24 hr) was 25 26(2 to 106); plasma norepineph-
rine (pg/mi) was 587 363 (125 to 1519); plasma vasopressin
(pg/mI) was 2.56 1.71(0.1 to 6.0); total blood volume (ml) was
5605 1228 (3148 to 7710); blood volume as % of predicted
I r=0,353 J .•P<0.05
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Fig. 1. The hemodynamic correlates of GFR in patients with conges-
tive heart failure: cardiac index (A), renal blood flow (B), and renal
fraction of cardiac output (C).
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Table 2. Results of stepwise multiple regression analysis of all
parameters that influence GFR
Variable /3-coefficient sE F
% Explained
variance
Intercept 83.663 7.435 — —
Renal blood flow 0.151 0.008 338.10 0.686
Filtration fraction 184.424 16.893 119.19 0.247
Plasma renin activity —0.242 0.079 9.25 0.010
Serum sodium —0.953 0.3923 5.90 0.010
Including the intercept, /3-coefficients (estimated slopes standard
error), critical F and % of variance explained (partial R2), for each
parameter in the equation.
normal was 119 21 (80 to 164); urinary sodium excretion
(mEqI24 hr) was 42 31(2 to 116); serum sodium (mmol/liter)
was 135 4(126 to 143); and serum chloride (mmol/liter) was 97
13 (82 to 107). There were no correlations between GFR and
these parameters, with the exception of serum sodium (r =
0.447, P < 0.01).
Age related changes in renal hemodynamics and function
Age appeared to influence renal hemodynamics and function,
as several significant correlations were identified. This included
an inverse relationship of age with GFR (r =
—0.485, P < 0.003)
and filtration fraction (r =
—0.510, P < 0.002), and a positive
relationship between age and renal vascular resistance (r =
0.421, P < 0.02). There was an inverse relationship between age
and both renal plasma flow and renal blood flow, however,
these did not achieve statistical significance.
To further evaluate the influence of age, we compared the
regression of age versus renal parameters for our congestive
heart failure patients with known age-related changes in normal
subjects (Fig. 2). In heart failure, mean arterial pressure was
low in the younger patients and increased towards the normal
regression in older patients. Renal blood flow was abnormally
low, and decreased further, in parallel with normal subjects,
throughout all ages. A similar relationship was observed for
renal plasma flow (f ratio 97.5, P < 0.0001). GFR was abnor-
mally low, and decreased further, in parallel with normal
subjects, throughout all ages. In contrast to the normal gradual
increase of filtration fraction with aging, there was a striking
difference in heart failure. A compensatory increase of filtration
fraction was observed in the younger heart failure patients, and
sharply declined in older patients, where the normal regression
was intercepted. This occurred, despite the marked progressive
increase of renal vascular resistance in the heart failure pa-
tients, which diverged from normal, with aging.
Multiple regression analysis of factors influencing GFR
As age, systemic and renal hemodynamics, and hormonal
parameters may exert a simultaneous influence on GFR, these
parameters were entered into a stepwise multiple regression
analysis to determine which of the parameters exerted a greater
influence on GFR (Table 2). Of all the variables, renal blood
flow accounted for 69% of the observed variability of GFR in
congestive heart failure patients. Filtration fraction accounted
for an additional 25%. Minimal effects of plasma renin activity
(1%) and serum sodium (1%) were observed. All remaining
variables did not enter into the model. While age was consid-
ered in the list of dependent variables, it did not enter into the
final multiple regression analysis model. This suggested that the
other variables in the model were co-linear with age, or changed
in an age-related fashion, as demonstrated in Figure 2.
Discussion
Evaluating hemodynamic, hormonal, and volume factors that
may influence GFR, the present study established compelling
evidence for the flow dependence of GFR in congestive heart
failure. This was associated with a wide spectrum of intra-renal
compensation, as judged by the range of filtration fraction
observed in this study. Furthermore, we identified a co-linear
influence of age on renal function, identifying the severely
compromised renal status of elderly patients with congestive
heart failure.
The range of pulmonary wedge pressure, cardiac output, and
systemic vascular resistance observed in our patients indicated
a spectrum of mild to severe congestive heart failure. The
correlations of GFR with cardiac output and systemic vascular
resistance indicated that the severity of heart failure exerted a
hemodynamic influence on the extent of renal impairment. A
more significant relationship was observed between GFR and
renal hemodynamic parameters, such that regional control of
blood flow was more important than overall cardiac impair-
ment. In fact, when a multiple stepwise regression analysis was
performed, renal blood flow was found to account for 69% of
the observed variability in GFR. However, the overall renal
hemodynamic pattern observed in our patients was not what
might have been predicted by previous concepts. Patients with
the lowest GFR could not adequately increase efferent arterio-
lar tone in order to protect glomerular filtration. That is, the
lack of intra-renal compensation occurred in those patients who
had the lowest renal blood flow and the highest renal vascular
resistance, as the former was directly correlated with GFR, and
the latter was inversely correlated with GFR. This pattern in the
low GFR group suggests increased afferent arteriolar resis-
tance, rather than increased efferent arteriolar resistance. Thus,
intra-renal determinants of filtration fraction exert an indepen-
dent influence on GFR. The influence of abnormal flow patterns
on GFR becomes more apparent, when the data are considered
as a function of age-related changes.
The youngest congestive heart failure patients had relatively
preserved GFR, despite a reduction in renal blood flow, due to
a compensatory increase in filtration fraction, demonstrating
efferent vasoconstriction. The oldest heart failure patients had a
further reduction in GFR, as renal blood flow continued in a
precipitous decline, and filtration fraction was not increased in
a compensatory manner, indicating afferent vasoconstriction.
While age was not a major influence on GFR in the multiple
regression model, this reflects the fact that both renal blood
flow and filtration fraction were decreasing in an age-related
fashion. It is highly unlikely that the magnitude of these
abnormalities could be solely attributed to aging, and this was
confirmed by a comparison of our data to previously published
normal data [101. Using this comparative analysis, it was clear
that both aging and congestive heart failure exerted important
influences. In normal subjects, it is well recognized that there is
a progressive reduction of renal blood flow and function with
aging [10, 17, 18]. This is the result of reduction of total and
relative renal blood flow [19, 20], progressive glomerular scle-
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rosis [181, and formation of direct channels between afferent
and efferent arterioles, resulting in aglomerular arterioles [21,
22]. These processes are hastened with the superimposition of
acquired renal disease [18], such as the low flow state of
congestive heart failure, and may account for the abnormal
renal hemodynamic pattern that we observed in our elderly
patients.
In human studies, it is difficult to identify intra-renal hemo-
dynamic and hormonal mechanisms that may account for the
observations made in the present study, but the overall issues
regarding relative afferent and efferent vasoconstriction must be
addressed. While GFR was flow dependent and did not signif-
icantly correlate with neurohormonal parameters, we cannot
minimize the likely importance of the renal neurohormonal
milieu in intra-renal blood flow. Angiotensin II is felt to prefer-
entially constrict the efferent arteriole [23—26], and thereby
increases filtration fraction. A lack of correlation with GFR may
be due to the fact that plasma renin activity was increased, on
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average, for all the patients in this study, which is typical for the
majority of diuretic-treated patients with congestive heart fail-
ure [11, 27—29]. Afferent vasoconstriction can occur as a result
of increased sympathetic nervous system activity [24, 26,
30—32]. Plasma norepinephrine levels were increased in our
patients, consistent with earlier studies [33—35], suggesting that
this enhanced sympathetic activity may be important for the
intra-renal regulation of glomerular filtration. The concept of
flow dependency of glomerular filtration rate in the presence of
severely reduced glomerular perfusion has been studied in
Munich-Wistar rats [26, 36, 37]. The simultaneous reduction of
GFR and filtration fraction in the older heart failure patients
may therefore provide a clinical counterpart to the findings in
experimental models. The marked reduction of glomerular
filtration rate and inadequate increase of filtration fraction could
be explained by a combination of three factors: I) low glomer-
ular plasma flow, 2) low transcapillary hydraulic pressure, and
3) reduced ultrafiltration coefficient, according to studies of
Munich-Wistar rats 126, 36, 37] and has been postulated by
Myers et al 138]. Increased sympathetic nervous system activity
as found in our patients, likely contributed to the low glomer-
ular plasma flow by increasing preglomerular tone [24, 26, 32,
39]. Also mean arterial pressure was low compared to normal
subjects, indicating a low transcapiflary hydraulic pressure. We
could not measure the ultrafiltration coefficient, which may be
reduced by increased activity of the renin-angiotensin system
[36, 40] and by increased plasma norepinephrine 132] and
vasopressin [40], hormonal pathways which were all activated
in our patients. We cannot exclude the influence of other
hormonal mechanisms, such as renal prostaglandins 141] and
atrial natriuretic factor [42—44].
Previous assessment of GFR in patients with chronic conges-
tive heart failure have been limited. In many early studies of
GFR, the clinical diagnosis of congestive heart failure was the
result of valvular heart disease [1, 2, 4—7] and very few patients
had severe failure that is commensurate with current patient
populations. While more recent clinical studies have assessed
the influence of congestive heart failure on renal blood flow [3,
45—47], steady state GFR has been studied in only limited
numbers of patients [22, 23, 45, 46, 48—50]. Since we did not
measure the extraction of PAH it may be argued that renal
plasma flow could have been underestimated in this study.
However, previous studies have shown that the extraction ratio
of PAH, in congestive heart failure, is similar to that of normal
individuals [1, 4, 5, 7, 19]. Moreover, in experimental shock,
renal blood flow could be reduced to as low as 3% of normal
without decreasing the renal extraction of PAH [50]. We cannot
exclude the potential influence of loop diuretic therapy on our
results. All of our patients had been treated with furosemide,
although it was held on the morning of study, to avoid its acute
effects. Furosemide remains the mainstay of treatment of
congestive heart failure and is typical of the baseline status of
the congestive heart failure population. We are well aware,
however, that the alteration of sodium intake may profoundly
influence hemodynamic and hormonal characteristics of con-
gestive heart failure 151]. Further studies will be necessary to
determine the impact of 1oop diuretic therapy on GFR across a
wide spectrum of age-adjusted congestive heart failure patients.
In summary, the present study demonstrates the flow depen-
dence of GFR in patients with congestive heart failure. The
renal hemodynamic pattern was not uniform, in that patients
with the greatest reduction of GFR actually had the lowest
filtration fraction, despite an overall greater increase in renal
vascular resistance, indicating the predominance of afferent
vasoconstrictor mechanisms. The multiple regression analysis
showed that the reduction of renal blood flow had the greatest
effect in impairing GFR. Vasoaetive hormones and blood vol-
ume were generally increased in our patients, but there was no
clear cut relationship of neurohormonal determinants to GFR.
While renal blood flow and GFR were reduced overall, there
was a further age-related effect, with the lowest renal blood flow
and GFR observed in the older congestive heart failure patients.
Distinct age-associated hemodynamic patterns governing GFR
were observed, demonstrating the fragile nature of renal func-
tion in the elderly heart failure population.
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